Therefore, while over-expression of the Cell Cycle pathway points to early stage breast cancer deaths in the worst outcome subtype, copy number loss of p53 signaling pathway characterises the subtype with intermedia survival outcome. The gene discussed is TP53; the disease is breast carcinoma.